| abstract |
The present invention relates to bromodomain inhibitors, and provides a compound represented by general formula I, its pharmaceutically acceptable salts, enantiomers, diastereomers, atropisomers, racemates Forms, polymorphs, solvates or isotopically labeled compounds (including deuterium substitutions), methods for their preparation, pharmaceutical compositions containing them and their use in pharmacy. |